t(8;21)(q22;q22) RUNX1/RUNX1T1
2016-05-01 Wilma Kroes  , Wilma Kroes   Affiliation1.Department of Clinical Genetics, Leiden University Medical Center, Leiden; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands. [email protected]; [email protected]
2.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
Clinics and Pathology
Disease
Phenotype stem cell origin
Epidemiology
Clinics

Cytology
Prognosis
Cytogenetics

Cytogenetics molecular
Additional anomalies
Variants
Genes Involved and Proteins
Result of the Chromosomal Anomaly

Description
Detection protocole
Description
Oncogenesis
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 35065680 | 2022 | Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | 172 |
| 31817911 | 2019 | Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription. | 150 |
| 36068610 | 2022 | ASXL1/2 mutations and myeloid malignancies. | 129 |
| 39177514 | 2024 | Mutational cooperativity of RUNX1::RUNX1T1 isoform 9a and oncogenic NRAS in zebrafish myeloid leukaemia. | 96 |
| 33928020 | 2021 | Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance. | 87 |
| 36874378 | 2023 | Therapy-related core binding factor acute myeloid leukemia. | 86 |
| 33217477 | 2021 | The RUNX1/RUNX1T1 network: translating insights into therapeutic options. | 83 |
| 35563085 | 2022 | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia. | 82 |
| 34766123 | 2020 | Modelling t(8;21) acute myeloid leukaemia - What have we learned? | 80 |
| 27798625 | 2016 | The genomic landscape of core-binding factor acute myeloid leukemias. | 79 |
| 33531067 | 2021 | MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3'UTR. | 72 |
| 37019972 | 2023 | Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. | 71 |
| 33483506 | 2021 | RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia. | 70 |
| 28516957 | 2017 | ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia. | 68 |
| 40991849 | 2025 | Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia. | 67 |
| 36845715 | 2023 | Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients. | 66 |
| 26361793 | 2015 | Overexpression and knockout of miR-126 both promote leukemogenesis. | 65 |
| 34125173 | 2021 | Tumor suppressor function of Gata2 in acute promyelocytic leukemia. | 64 |
| 35662693 | 2022 | CNST is Characteristic of Leukemia Stem Cells and is Associated With Poor Prognosis in AML. | 64 |
| 39243082 | 2024 | Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia. | 62 |
| 35902872 | 2022 | RUNX1T1 function in cell fate. | 61 |
| 37841755 | 2023 | CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition. | 61 |
| 37790524 | 2023 | Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid Leukemia. | 55 |
| 38454121 | 2024 | Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia. | 55 |
| 36916780 | 2023 | RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification. | 54 |
| 36613512 | 2022 | AML1-ETO-Related Fusion Circular RNAs Contribute to the Proliferation of Leukemia Cells. | 54 |
| 34200630 | 2021 | DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML). | 53 |
| 40829168 | 2025 | Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging. | 52 |
| 35973983 | 2022 | Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia. | 52 |
| 26595813 | 2016 | PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia. | 51 |
| 33836581 | 2021 | Enhanced cytarabine-induced killing in OGG1-deficient acute myeloid leukemia cells. | 51 |
| 36442087 | 2022 | Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia. | 47 |
| 40307896 | 2025 | CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases. | 47 |
| 35008106 | 2022 | Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia. | 45 |
| 39272967 | 2024 | Minimal Requirements for Cancer Initiation: A Comparative Consideration of Three Prototypes of Human Leukemia. | 45 |
| 30093396 | 2018 | ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion. | 45 |
| 40612409 | 2025 | Cellular hierarchy for understanding heterogeneity of acute myeloid leukaemia with t(8;21)/RUNX1-RUNX1T1. | 44 |
| 35326705 | 2022 | CDK6 Degradation Is Counteracted by p16(INK4A) and p18(INK4C) in AML. | 42 |
| 42422007 | 2026 | Unmasking hidden high risk in RUNX1::RUNX1T1 pediatric AML: Development of a novel prognostic model. | 42 |
| 31896782 | 2020 | The clinical mutatome of core binding factor leukemia. | 40 |
| 40784929 | 2025 | t(8;21)AML patients with RUNX1e6::RUNX1T19a splice variant have poor prognosis. | 37 |
| 38017299 | 2024 | Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML. | 37 |
| 36291567 | 2022 | Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia. | 33 |
| 36939402 | 2023 | Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study. | 33 |
| 40304077 | 2025 | Clinical characteristics and therapeutic determinants of RUNX1::RUNX1T1 differ from those of CBFB::MYH11 acute myeloid leukemia. | 33 |
| 31364309 | 2019 | High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia. | 33 |
| 32115572 | 2020 | ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells. | 32 |
| 27252013 | 2016 | ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation. | 31 |
| 32757686 | 2020 | Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1. | 29 |
| 39857993 | 2025 | PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid Leukemia. | 28 |
| 34921223 | 2021 | Epigenetic silencing of UBXN8 contributes to leukemogenesis in t(8;21) acute myeloid leukemia. | 25 |
| 38802593 | 2024 | Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases. | 25 |
| 30281597 | 2018 | Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes. | 23 |
| 36833323 | 2023 | Fusion Gene-Based Classification of Variant Cytogenetic Rearrangements in Acute Myeloid Leukemia. | 20 |
| 35765876 | 2022 | Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with RUNX1::RUNX1T1. | 20 |
| 39735012 | 2024 | Characterization of Acute Myeloid Leukemia With RUNX1/RUNX1T1 Gene Rearrangement: Clinical, Hematological, and Morphological Features. | 19 |
| 40647534 | 2025 | KDM6A Variants Increased Relapse Risk in Adult Acute Myeloid Leukemia. | 19 |
| 38528080 | 2024 | Differential prognostic values of the three AKT isoforms in acute myeloid leukemia. | 17 |
| 34148054 | 2021 | RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner. | 15 |
| 37621071 | 2023 | Co-existence of RUNX1-RUNX1T1 and BCR-ABL1 in acute myeloid leukemia: a case report. | 15 |
| 39691258 | 2024 | RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis. | 14 |
| 30623623 | 2019 | Reclassification of Acute Myeloid Leukemia According to the 2016 WHO Classification. | 13 |
| 33816105 | 2021 | Primary peritoneal myeloid sarcoma in association with CBFB/MYH11 fusion. | 13 |
| 40119466 | 2025 | Dynamin2 mutations in newly diagnosed acute myeloid leukemia: clinical characteristics, and prognostic significance. | 11 |
| 37101551 | 2023 | Pediatric chronic myeloid leukemia in myeloid blast crisis. | 10 |
| 38633925 | 2024 | RUNX1::RUNX1T1 Acute Myeloid Leukemia Cytogenetically Showing t(6;8)(p23;q22). | 8 |
| 40329358 | 2025 | CD19 CAR-T in relapsed t(8;21) AML: a single-center prospective phase II clinical trial. | 7 |
| 37519108 | 2023 | Hemophagocytic Lymphohistiocytosis in RUNX1::RUNX1T1 Positive AML with Blast Count Below 20%. | 4 |
| 40009498 | 2025 | Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML. | 0 |
| 39264725 | 2024 | Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells. | 0 |
| 39179670 | 2024 | STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells. | 0 |
| 22032582 | 2011 | Core-binding factor acute myeloid leukemia. | 0 |
| 39864466 | 2025 | Acute myeloid leukemia with t(8;21) translocation: Molecular pathogenesis, potential therapeutics and future directions. | 0 |
| 35152350 | 2022 | UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8. | 0 |
| 31281149 | 2019 | [Genetic abnormalities in AML]. | 0 |
| 36653696 | 2023 | Comprehensive molecular understanding of pediatric acute myeloid leukemia. | 0 |
| 36476886 | 2022 | [Molecular Genetic Characteristics of Acute Myeloid Leukemia Patients with CBFβ-MYH11 Positive]. | 0 |
| 30846508 | 2019 | More than a fusion gene: the RUNX1-RUNX1T1 AML. | 0 |
| 29872884 | 2018 | Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. | 0 |
| 40931047 | 2025 | Longitudinal single-cell analysis reveals treatment-resistant stem and mast cells with potential treatments for pediatric AML. | 0 |
| 38175376 | 2023 | Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist? | 0 |
| 41689467 | 2026 | Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions. | 0 |
| 35900542 | 2022 | Acute myeloid leukemia patients with variant or unusual translocations involving chromosomes 8 and 21 - A comprehensive cytogenetic profiling of three cases with review of literature. | 0 |
| 38469780 | 2024 | AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR. | 0 |
| 37102302 | 2023 | TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia. | 0 |
| 34739701 | 2022 | Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patients. | 0 |
| 24976338 | 2014 | RUNX1T1/MTG8/ETO gene expression status in human t(8;21)(q22;q22)-positive acute myeloid leukemia cells. | 0 |
| 37925056 | 2024 | Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry. | 0 |
| 40828779 | 2025 | Measurable residual disease dynamics holding prognostic significance in pediatric patients with RUNX1::RUNX1T1-positive AML: results from AML-CAMS serial trials. | 0 |
| 36044298 | 2023 | Clinical and Cytogenetic Characteristics of Children With Leukemia 20-Year Retrospective Study. | 0 |
| 24342949 | 2014 | Pontin is a critical regulator for AML1-ETO-induced leukemia. | 0 |
| 41966916 | 2026 | SOHO State of the Art Updates and Next Questions: Is Favorable-risk AML Always Favorable? | 0 |
| 39535162 | 2024 | A RUNX1: RUNX1T1 AML with a simultaneous false positive KMT2A rearrangement: FISH interpretation pitfalls. | 0 |
| 39182671 | 2024 | Tailored Digital PCR Follow-Up of Rare Fusion Transcripts after Initial Detection through RNA Sequencing in Hematological Malignancies. | 0 |
| 39191510 | 2024 | WT1 together with RUNX1::RUNX1T1 targets DUSP6 to dampen ERK activity in acute myeloid leukaemia. | 0 |
| 35264498 | 2022 | [A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)]. | 0 |
| 25635758 | 2015 | Emerging diagnostic and therapeutic approaches in core binding factor acute myeloid leukaemia. | 0 |
| 38569861 | 2024 | [Veno-venous extracorporeal membrane oxygenation for capillary leak syndrome during induction chemotherapy in acute myeloid leukemia]. | 0 |
| 42855473 | 2026 | Mitochondria transfer via tunneling nanotubes drives macrophage immunosuppression and metabolic reprogramming in pediatric AML. | 0 |
| 42629390 | 2026 | Oncogenic DHX15 mutation enhances mitochondrial metabolism and sustains leukemia stemness. | 0 |
Bibliography
No bibliography items were found for this article.
Summary
Fusion gene

Citation
Wilma Kroes ; Wilma Kroes
t(8;21)(q22;q22) RUNX1/RUNX1T1
Atlas Genet Cytogenet Oncol Haematol. 2016-05-01
Online version: http://atlasgeneticsoncology.org/haematological/1019/t(8
Historical Card
1997-09-01 t(8;21)(q22;q22) RUNX1/RUNX1T1 by Jean-Loup Huret,Jean-Loup Huret  Affiliation
